As of Oct 15
| +0.27 / +0.52%|
The 8 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 58.00, with a high estimate of 75.00 and a low estimate of 48.84. The median estimate represents a +11.90% increase from the last price of 51.83.
The current consensus among 11 polled investment analysts is to Buy stock in Bristol-Myers Squibb Co. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.